510(k) K082661
K082661 is an FDA 510(k) premarket notification submitted by Princeton BioMeditech Corp. for the device "BIOSTREP A, BIOSIGN STREP A, STATUSFIRST STREP A". The FDA issued a decision of Substantially Equivalent on October 6, 2008. The device falls under product code GTY (Antigens, All Groups, Streptococcus Spp.), a Class I device regulated under 21 CFR 866.3740. Princeton BioMeditech Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 6, 2008
- Date Received
- September 12, 2008
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antigens, All Groups, Streptococcus Spp.
- Device Class
- Class I
- Regulation Number
- 866.3740
- Review Panel
- MI
- Submission Type